23.03.2015 • News • Karl-Ludwig Kley • Manager Magazin • Merck

Oschmann Set to Become Merck KGaA's CEO

Germany's Merck KGaA will promote its deputy chief executive, Stefan Oschmann, to replace current CEO Karl-Ludwig Kley next year, Manager Magazin reported on Friday.

Oschmann, 57, would take on the new role next year after the group's annual shareholder meeting in April 2016 or in September next year at the latest, when Kley's current contract expires.

The German drugs and chemicals maker last September appointed Oschmann, the head of its pharma business at the time, as deputy chief executive from January 2015 on, sharing strategic management functions and representation of the company with Kley (63).

A Merck spokeswoman said a decision on Kley's succession has not yet been made and that this would be a matter for the family-controlled group's board of partners.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Top-Feature